Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 6, 2015

Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes
Nov 5, 2015

Sanofi and Hanmi Announce License Agreement To Develop Portfolio of Long-Acting Diabetes Treatments
Nov 5, 2015

Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015
Oct 30, 2015

REVISIÓN: Sanofi US Anuncia El Retiro Voluntario Del Mercado a Nivel Nacional De Todas Las INYECCIONES AUVI-Q® Debido a la Posibilidad de Incluir Una Dosis Incorrecta
Oct 30, 2015

UPDATED: Sanofi US Issues Voluntary Nationwide Recall of All Auvi-Q® Due to Potential Inaccurate Dosage Delivery
- Photos 1
Oct 29, 2015

Sanofi grew sales and business EPS in Q3 2015
Oct 29, 2015

Sanofi Grew Sales and Business EPS in Q3 2015
- Photos 1
Oct 1, 2015

Sanofi Announces Launch of Authorized Generic Version of Arava® (Leflunomide) Tablets
Sep 29, 2015

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

- First New Drug Application for a GLP-1 receptor agonist to include CV outcomes data -
Sep 28, 2015

Sanofi Reaches Patent Settlement on Lantus® SoloSTAR®
- Photos 1

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.